Mirae Asset Global ETFs Holdings
ABEO icon

Mirae Asset Global ETFs Holdings’s Abeona Therapeutics ABEO Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$124K Sell
20,110
-650
-3% -$3.57K ﹤0.01% 2710
2026
Q1 		$93K Buy
20,760
+518
+3% +$2.59K ﹤0.01% 2704
2025
Q4 		$107K Sell
20,242
-241
-1% -$1.21K ﹤0.01% 2644
2025
Q3 		$108K Sell
20,483
-3,423
-14% -$21.7K ﹤0.01% 2623
2025
Q2 		$136K Buy
+23,906
New +$136K ﹤0.01% 2454

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OIA
OneDigital Investment Advisors Overland Park, Kansas $11.8B AUM 21.23% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's ABEO Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings reduced its Abeona Therapeutics (ABEO) stake by 3.1% in Q2 2026, selling an estimated $3.57K and leaving 20,110 shares worth $124K. The position accounts for ﹤0.01% of the portfolio, ranked #2710.

Mirae Asset Global ETFs Holdings first reported a position in ABEO in Q2 2025 and has held it in 5 quarters since. The position peaked at $136K in Q2 2025. 126 funds tracked by Wall St. Rank hold ABEO as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 20,110 shares of Abeona Therapeutics worth $124K as of Q2 2026.
  • Mirae Asset Global ETFs Holdings sold 650 Abeona Therapeutics shares in Q2 2026, an estimated $3.57K.
  • Abeona Therapeutics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2710 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Abeona Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • Mirae Asset Global ETFs Holdings's Abeona Therapeutics position peaked at $136K in Q2 2025.
  • 126 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.